Ultralife (ULBI) Projected to Post Quarterly Earnings on Thursday

Ultralife (NASDAQ:ULBI) will likely be announcing its Q2 2026 results before the market opens on Thursday, July 23rd. Analysts expect Ultralife to post earnings of $0.19 per share and revenue of $55.00 million for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 6, 2026 at 12:00 PM ET.

Ultralife (NASDAQ:ULBI) last issued its earnings results on Friday, May 8th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.18). The business had revenue of $47.45 million for the quarter, compared to analysts’ expectations of $52.40 million. Ultralife had a positive return on equity of 1.15% and a negative net margin of 4.37%.

Ultralife Stock Up 1.6%

ULBI opened at $5.75 on Thursday. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.56 and a quick ratio of 1.23. Ultralife has a 12 month low of $4.90 and a 12 month high of $9.52. The stock has a market capitalization of $95.80 million, a P/E ratio of -11.50 and a beta of 0.78. The business has a 50 day simple moving average of $6.37 and a 200-day simple moving average of $6.41.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Ultralife from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, June 12th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

Insider Buying and Selling

In other news, Director Bradford T. Whitmore bought 67,302 shares of the stock in a transaction on Tuesday, May 26th. The shares were bought at an average price of $6.81 per share, with a total value of $458,326.62. Following the completion of the acquisition, the director owned 2,050,637 shares of the company’s stock, valued at approximately $13,964,837.97. This trade represents a 3.39% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired 108,878 shares of company stock worth $714,928 in the last quarter. 42.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Janney Montgomery Scott LLC grew its stake in Ultralife by 6.8% in the 4th quarter. Janney Montgomery Scott LLC now owns 507,800 shares of the technology company’s stock valued at $2,905,000 after acquiring an additional 32,133 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in Ultralife by 210.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 219,018 shares of the technology company’s stock worth $1,494,000 after acquiring an additional 148,542 shares during the last quarter. Raymond James Financial Inc. raised its position in Ultralife by 14.5% during the second quarter. Raymond James Financial Inc. now owns 116,085 shares of the technology company’s stock worth $1,042,000 after acquiring an additional 14,667 shares during the last quarter. Ancora Advisors LLC raised its position in Ultralife by 24.3% during the third quarter. Ancora Advisors LLC now owns 105,321 shares of the technology company’s stock worth $718,000 after acquiring an additional 20,562 shares during the last quarter. Finally, Citadel Advisors LLC lifted its holdings in shares of Ultralife by 78.9% in the third quarter. Citadel Advisors LLC now owns 80,921 shares of the technology company’s stock valued at $552,000 after purchasing an additional 35,695 shares in the last quarter. Institutional investors and hedge funds own 30.68% of the company’s stock.

About Ultralife

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.